Formulation and Analytical Development for Low-Dose Oral Drug Products
Tested-and-proven strategies for developing and manufacturing low-dose oral drug productsDeveloping and commercializing a low-dose oral drug product presents a number of hurdles that can quickly offset the drug's benefits. Written by a team of leading scientists in drug development, this book collects and synthesizes the knowledge, techniques, and strategies needed for developing low-dose drugs successfully. With this book's practical support, readers can overcome the hurdles at all stages in drug development, from formulation to manufacturing and control to regulatory compliance.Following an overview of the drug discovery and development pro…
Mehr
CHF 186.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V112:
Lieferbar in ca. 10-20 Arbeitstagen
Produktdetails
- ISBN: 978-0-470-05609-7
- EAN: 9780470056097
- Produktnummer: 4051905
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2009
- Seitenangabe: 492 S.
- Masse: H23.9 cm x B16.4 cm x D2.9 cm 782 g
- Gewicht: 782
Über den Autor
Jack Zheng, PhD, is Research Advisor and Team Leader in the Pharmaceutical Sciences R&D Division of Eli Lilly and Company and Adjunct Professor at Beijing University. Dr. Zheng is the author of more than thirty articles and several book chapters. He has been invited to present his work at numerous national and international scientific meetings. He was involved in more than ten new drug product development and regulatory filing with the Food and Drug Administration.
3 weitere Werke von Jack Zheng:
Bewertungen
Anmelden